Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 3 , Pages 215-226 , May 2009

Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes

  • David L. Weimer

      Affiliations

    • Robert M. La Follette School of Public Affairs, University of Wisconsin-Madison, Madison, WI, USA
    • ,
  • Mark A. Sager

      Affiliations

    • Wisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    • Corresponding Author InformationCorresponding author. Tel.: 608-829-3300; Fax: 608-829-3315.

References 

  1. Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord. 2001;15:169–173
  2. Bloom BS, de Pouvourville N, Straus WL. Cost of illness of Alzheimer's disease: how useful are current estimates?. Gerontologist. 2003;43:158–164
  3. Knapp M, Prince M. Dementia UK: the full report. London: Alzheimer's Society; 2007;
  4. Taylor DH, Sloan FA. How much do persons with Alzheimer's disease cost Medicare?. J Am Geriatr Soc. 2000;48:639–646
  5. Kaiser Family Foundation. State health facts. 2006;Available at www.statehealthfacts.org
  6. Lopez OL, Becker JT, Saxton J, Sweet RA, Klunk W, DeKosky ST. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. J Am Geriatr Soc. 2005;53:83–87
  7. Mittelman MS, Haley WE, Clay OJ, Roth DL. Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology. 2006;67:1592–1599
  8. Valcour VG, Masaki KH, Curb JD, Blanchette PL. The detection of dementia in the primary care setting. Arch Intern Med. 2000;160:2964–2968
  9. Boise L, Neal MB, Kaye J. Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol Med Sci. 2004;59A:621–626
  10. Magsi H, Malloy T. Under-recognition of cognitive impairment. I. Assisted living facilities. J Am Geriatr Soc. 2005;53:295–298
  11. Boise L, Camicioli R, Morgan DL, Rose JH, Congleton L. Diagnosing dementia: perspectives of primary care physicians. Gerontologist. 1999;39:457–464
  12. United States Preventive Services Task Force. The guide to clinical preventive services. Rockville, MD: Agency for Healthcare Research and Quality; 2005;
  13. Dale W, Hemmerich J, Hill EK, Hougham GW, Sachs GA. What correlates with the intention to be tested for mild cognitive impairment (MCI) in healthy older adults?. Alzheimer Dis Assoc Disord. 2008;22:144–152
  14. Dale W, Hougham GW, Hill EK, Sachs GA. High interest in screening and treatment for mild cognitive impairment in older adults: a pilot study. J Am Geriatr Soc. 2006;54:1388–1394
  15. Boustani M, Callahan CM, Unverzagt FW, Austrom MG, Perkins AJ, Fultz B, et al. Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med. 2005;20:572–577
  16. Geldmacher DS. Treatment guidelines for Alzheimer's disease: redefining perceptions of primary care. Primary care companion. J Clin Psychiatry. 2007;9:113–121
  17. Arias E. United States life tables, 2003. Natl Vital Stat Rep. 2006;54:1–40
  18. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci. 2005;229/230:43–49
  19. Gasper MC, Ott BR, Lapane KL. Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?. Am J Geriatr Pharmacother. 2005;3:1–7
  20. Lopez-Pousa S, Olmo JG, Franch JV, Estrada AT, Cors OS, Nierga IP, et al. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine. Age Ageing. 2006;35:365–371
  21. Mays J, Brenner M, Neuman T, Cubanski J, Claxton G. Estimates of Medicare beneficiaries—out-of-pocket drug spending in 2006. Menlo Park, CA: Kaiser Family Foundation; 2004;
  22. Hauber AB, Gnanasakthy A, Snyder EH, Bala MV, Richter A, Mauskopf JA. Potential savings in the cost of caring for Alzheimer's disease: treatment with rivastigmine. Pharmacoeconomics. 2000;17:351–360
  23. Bell CM, Araki SS, Neumann PJ. The association between caregiver burden and caregiver health-related quality of life in Alzheimer's disease. Alzheimer Dis Assoc Disord. 2001;15:129–136
  24. Wisconsin Department of Health and Family Services. Wisconsin nursing homes and residents. Madison, WI: Division of Health Care Financing, Bureau of Health Information; 2006;
  25. Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J, et al. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology. 1999;52:1138–1145
  26. Lave JR, Frank RG, Schulberg HC, Kamlet MS. Cost-effectiveness of treatments for major depression in primary care practice. Arch General Psychiatry. 1998;55:645–651
  27. Covinsky KE, Newcomer R, Fox P, Wood J, Sands L, Dane K, et al. Patient and caregiver characteristics associated with depression in caregivers of patients with dementia. J Gen Intern Med. 2003;18:1006–1014
  28. Boardman AE, Greenberg DH, Vining AR, Weimer DL. Cost-benefit analysis: concepts and practice. 3rd ed.. Upper Saddle River, NJ: Prentice Hall; 2006;
  29. Bullock R, Dengiz A. Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to five years. Int J Clin Pract. 2005;59:817–822
  30. Sabbagh M, Farlow M, Relkin N, Beach T. Do cholinergic therapies have disease-modifying effects in Alzheimer's disease?. Alzheimers Dement. 2006;2:118–125
  31. Matthews HP, Korbey J, Wilkenson DG, Rowden J. Donepezil in Alzheimer's disease: eighteen months from Southampton Memory Clinic. Int J Geriatr Psychiatry. 2000;15:713–720
  32. Small GW, Kaufer D, Mendiondo MS, Quarg P, Spiegel R. Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years. Int J Clin Pract. 2005;59:473–477
  33. Karlawish JHT, Klocinski JL, Merz J, Clark CC, Asch DA. Caregivers' preferences for the treatment of patients with Alzheimer's disease. Neurology. 2000;55:1008–1014
  34. Mittelman MS, Roth DL, Coon DW, Haley WE. Sustained benefit of supportive intervention for depressive symptoms in caregivers of patients with Alzheimer's disease. Am J Psychiatry. 2004;161:850–856
  35. Newcomer R, Spitalny M, Fox P, Yordi C. Effects of the Medicare Alzheimer's disease demonstration on the use of community-based services. Health Serv Res. 1999;34:645–667
  36. Barker WW, Luis C, Harwood D, Loewenstein D, Bravo M, Ownby R, et al. The effect of a memory screening program on the early diagnosis of Alzheimer disease. Alzheimer Dis Assoc Disord. 2005;19:1–7
  37. Gruber-Baldini AL, Stuart B, Zukerman IH, Simoni-Wastila L, Miller S. Treatment of dementia in community dwelling and institutionalized Medicare beneficiaries. J Am Geriatr Soc. 2007;55:1508–1516
  38. Callahan CM, Boustani MA, Unverzagt FW, Autrom MG, Damush TM, Perkins AJ, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006;295:2148–2157
  39. Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher-Thompson D, et al. Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized controlled trial. Ann Intern Med. 2006;145:727–738
  40. Borson S, Scanlan J, Hummel J, Gibbs K, Lessig M, Zuhr E. Implementing routine cognitive screening of older adults in primary care: process and impact of physician behavior. Soc Gen Intern Med. 2007;22:811–817
  41. Brayne C, Fox C, Boustani M. Dementia screening in primary care: is it time?. JAMA. 2007;298:2409–2411
  42. Carpenter BD, Xiong C, Porensky EK, Lee MM, Brown PJ, Coats M, et al. Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment. J Am Geriatr Soc. 2008;56:405–412
  43. Salloway S, Mintzer J, Weiner MF, Cummings JL. Perspectives: disease-modifying therapies in Alzheimer's disease. Alzheimer's Dement. 2008;4:65–79

PII: S1552-5260(09)00029-6

doi: 10.1016/j.jalz.2009.01.028

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 3 , Pages 215-226 , May 2009

Article Tools

* Image Usage & Resolution